Cargando…
Multi-Omics Alleviates the Limitations of Panel Sequencing for Cancer Drug Response Prediction
SIMPLE SUMMARY: Cancer is a complex, heterogeneous collection of diseases with hundred of different subtypes. Genomic aberrations that are primarily thought to be the root causes of different cancers have been clinically used as evidence for both the diagnosis and also matching individual patients t...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688044/ https://www.ncbi.nlm.nih.gov/pubmed/36428696 http://dx.doi.org/10.3390/cancers14225604 |